The rise of bioconjugates beyond traditional ADCs is reshaping the biopharmaceutical landscape. As we pioneer new frontiers in next-gen therapeutics, how can we tackle the challenges along the development of novel bioconjugates?
Join us to delve into the forefront of bioconjugation innovation. Learn how our comprehensive end-to-end solutions and ADC in vivo & in vitro characterization services can help you navigate the challenges and accelerate your therapeutic breakthroughs across various disease indications.
Agenda
11:00-11:30
Registration and Opening
11:30-12:00
Empowering Bioconjugates Innovation and Development with WuXi XDC's Integrated Discovery and CMC Solutions
Speaker: Dr.Jimmy Li, CEO, WuXi XDC
12:00-12:15
Enhancing mab and BsAb Discovery to support novel ADC discovery: From Strategic Design to Fit-for-Purpose Screening and Characterization
Speaker: Dr.Winfried Elis, Sr. Business Development Manager, WuXi Biologics
12:15-12:30
Q&A Session
12:30-14:00
Standing Lunch & Networking
Event Highlights →
• Discover emerging trends and breakthroughs in the ADCs/Bioconjugations field
• Exchange ideas with fellow scientists, researchers, and industry experts
• Complimentary lunch and refreshments
We would be truly honored by your presence and look forward to the opportunity to connect and collaborate with you during this exciting event.
